Factors Influencing 25‐Year Survival in Pediatric Liver Transplant Recipients
Pediatric Transplantation · 2025
DOI: 10.1111/petr.70189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, 2025. Verfasst von Garrett Wortham und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Student Affairs, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Liver Transplantation, Cholestasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This study assesses the impact of cholestatic liver disease, including biliary atresia, on 25‐year survival post‐transplantation and additional factors influencing long‐term outcomes after pediatric liver transplantation.
Methods
We conducted a retrospective analysis of pediatric liver transplant recipients (1987–1998) using de‐identified data from the OPTN 2023 Liver Database. After exclusions for multi‐organ transplants ( n = 222), prior transplants ( n = 2256), and deaths within 1 year ( n = 526), 2429 patients remained, including 645 with cholestatic disease. Univariate and multivariate analyses identified factors associated with 25‐year survival.
Results
A primary diagnosis of cholestatic disease was associated with improved 25‐year survival (OR: 0.67, p = 0.023). UNOS regions 2 (OR: 0.65, p = 0.009) and 5 were also associated with improved survival (OR: 0.72, p = 0.044). Decreased survival was associated with recipient ages 8–12 (OR: 1.84, p = 0.009) and 12–18 (OR: 2.90, p = 0.003), donor age ≥ 19 (OR: 1.42, p = 0.021), African‐American (OR: 1.94, p = 0.000) and other minority recipient ethnicities (OR: 2.49, p = 0.018), donor bilirubin ≥ 2 mg/dL (OR: 1.85, p = 0.022), and UNOS region 10 (OR: 1.62, p = 0.009).
Conclusion
This study evaluates 25‐year survival in pediatric liver transplant recipients while analyzing the protective influence of a cholestatic disease diagnosis. Older recipient and donor ages, minority recipient ethnicities, elevated donor bilirubin, and specific UNOS regions are associated with decreased 25‐year survival. Further research is needed to address outcome inequalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Student Affairs, Baylor College of Medicine, Houston, Texas, USA.
- Division of Abdominal Transplant, Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.
ORCID-Profile: Garrett Wortham, Megan Crawford, John Miggins
Zitieren
APA
Wortham, G., Crawford, M., Miggins, J., Huang, C. S., Goss, J. A., Rana, A., & Galván, N. T. (2025). Factors Influencing 25‐Year Survival in Pediatric Liver Transplant Recipients. Pediatric Transplantation. https://doi.org/10.1111/petr.70189
Vancouver
Wortham G, Crawford M, Miggins J, Huang CS, Goss JA, Rana A, et al. Factors Influencing 25‐Year Survival in Pediatric Liver Transplant Recipients. Pediatric Transplantation. 2025. doi:10.1111/petr.70189
BibTeX
@article{Wortham2025,
author = {Wortham, Garrett and Crawford, Megan and Miggins, John and Huang, Chun-Sing and Goss, John A and Rana, Abbas and Galván, Nhu Thao},
title = {Factors Influencing 25‐Year Survival in Pediatric Liver Transplant Recipients},
journal = {Pediatric Transplantation},
year = {2025},
doi = {10.1111/petr.70189}
}
EUVIMED